//fpnotebook.com/
Nebulized Albuterol
Aka: Nebulized Albuterol, Albuterol Nebulizer, Levalbuterol Nebulizer, Nebulized Xopenex
- Dosing: Albuterol
- Weight <10 kg or age under 12 months
- Albuterol 1.25 mg (0.25 cc) in 2 cc NS q1-4 hours
- Weight 10-35 kg or age 12 months to 10 years
- Albuterol 2.5 mg (0.5 cc) in 2 cc NS q1-4 hours
- Weight >35 kg or age over 10 years
- Albuterol 5.0 mg (1.0 cc) in 2 cc NS q1-4 hours
- Co-administered Medications (May add to Nebulizer)
- Ipratropium (Atrovent) 250 mcg (1.25 ml) q6-8 hours
- Cromolyn Sodium (Intal) (10 mg/ml) 2cc q6 hours
- Flunisolide (Nasalide) (.25%=250 ug/ml) 1-2 ml q6 hours
- Dosing: Levalbuterol (Xopenex) for Age over 12 years
- Dose: 0.63 to 1.25 mg nebulized q6-8 hours
- Adverse Effects
- Hypokalemia
- Tachycardia
- Efficacy
- Albuterol MDI and spacer/mask as effective as nebulizer
- Studied Wheezing children aged two years and younger
- Delgado (2003) Arch Pediatr Adolesc Med 157:76-80 [PubMed]
- Antiinflammatory added to nebulizer in RSV
- Study showed significant improvement
- Much fewer hospitalizations with Nasalide or Intal
- Reference
- Reijonen T (1996) Arch Pediatr Adolesc 150:512-7 [PubMed]
- Levalbuterol (Xopenex): Active R-Isomer of Albuterol
- Initially reported to have less Tachycardia than with Albuterol
- Appears to have no advantage over Albuterol
- References
- Bio (2011) J Pediatr Pharmacol Ther 16(3): 191-8 +PMID:22479161 [PubMed]
- Lam (2003) Am J Health Syst Pharm 60(19):1971-5 +PMID:14531242 [PubMed]
- (1999) Med Lett Drugs Ther 41(1054):51-3 [PubMed]